Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy

The invention refers to the use of a sigma ligand, preferably a sigma ligand of formula (I), to prevent or treat emesis induced by a chemotherapeutic agent or radioactivity, especially emesis induced by taxanes, vinca alkaloids or platin chemotherapeutic drugs.

Saved in:
Bibliographic Details
Main Authors Vela Hernández José Miguel, Codony-Soler Xavier, Zamanillo-Castanedo Daniel
Format Patent
LanguageEnglish
Published 10.10.2017
Subjects
Online AccessGet full text

Cover

Loading…